AQP4 and neuromyelitis optica: Since there was no evidence of CNS pathology, to verify the possibility that the fatigability of mice injected with AQP4 peptide or NMO-Ig originated from neuromuscular junction pathology using a nonbiased test, the mice were tested for their response to RNS and SFEMG.